Enochian BioSciences Inventor Named to Two Important Scientific Committees
03 juin 2019 07h00 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, June 03, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (Nasdaq: ENOB), a biotechnology company developing potentially curative and preventative genetically modified cellular and...
"London-patientens" vellykkede behandling understreger det kliniske potentiale ved Enochian Biosciences' genmodificerede celleterapi til HIV
08 mars 2019 17h41 HE
|
Enochian Bioscience
LOS ANGELES, March 08, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (Nasdaq: ENOB), et bioteknologiselskab, der udvikler potentielt helbredende og forebyggende, genetisk modificerede...
Successful Treatment of “London Patient” Underscores Clinical Potential of Enochian Biosciences’ Gene Modified Cellular Therapy for HIV
07 mars 2019 12h45 HE
|
Enochian Biosciences, Inc.
Enochian developing ENOB-HV-01 an autologous cell therapy as a potentially curative treatment for HIV LOS ANGELES, March 07, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (Nasdaq: ENOB), a...
Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair
07 janv. 2019 08h30 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (“Enochian”) a biopharmaceutical company focused on the development and commercialization of novel therapies for HIV/AIDS...
Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”
05 déc. 2018 08h30 HE
|
Enochian Biosciences, Inc.
– Appoints former President of GSK Global Vaccine business, Luc Debruyne, to Board of Directors – – Advances ENO-1001 for HIV by entering into research collaboration with Scripps Research –...
Enochian Biosciences to Present at Biotech Showcase 2019
03 déc. 2018 08h30 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (“Enochian”) (OTCQB: ENOB), a biopharmaceutical company developing potentially curative and preventative gene-modified cell...
Enochian Biosciences Announces Appointment of Dr. David Hardy to Scientific Advisory Board
20 juil. 2018 06h00 HE
|
Enochian Biosciences, Inc.
LOS ANGELES, July 20, 2018 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (“Enochian”) (OTCQB:ENOB), a biopharmaceutical company focused on the development and commercialization of novel therapies...